Protagonist Therapeutics EPS Basic from Discontinued Operations (Quarterly) Analysis

Protagonist Therapeutics, Inc. (PTGX)

85.19 +3.83 (+4.71%) USD | NASDAQ | Jan 14, 16:00

85.19 0.00 (0.00%) After-Hours: 20:00

View EPS Basic from Discontinued Operations (Quarterly) for PTGX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Discontinued Operations (Quarterly) Benchmarks

Start Trial

Johnson & Johnson	Upgrade
ADMA Biologics, Inc.	--
Bristol Myers Squibb Co.	--
MannKind Corp.	--
Regeneron Pharmaceuticals, Inc.	--